SILEXION THERAPEUTICS CORP Investing Cash Flow
SILEXION THERAPEUTICS CORP (SLXN) reported Investing Cash Flow of -$1.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-14
- SILEXION THERAPEUTICS CORP net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$1.00K.
- SILEXION THERAPEUTICS CORP net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was $0.00.
- SILEXION THERAPEUTICS CORP net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$7.00K.
- SILEXION THERAPEUTICS CORP net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $0.00.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.00K 10-Q · filed 2026-08-14 | -$1.00K 10-Q · filed 2026-08-14 | -$8.00K derived: sum of 3 quarters · filed 2026-08-14 | -$8.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $0.00 S-1/A · filed 2026-08-10 | -$7.00K derived: sum of 2 quarters · filed 2026-08-10 | -$7.00K derived: sum of 3 quarters · filed 2026-08-10 | -$8.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$7.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-08-10 | -$7.00K derived: sum of 2 quarters · filed 2026-08-10 | -$8.00K derived: sum of 3 quarters · filed 2026-08-14 | -$14.00K S-1/A · filed 2026-08-10 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-12 | -$1.00K derived: sum of 2 quarters · filed 2026-08-14 | -$7.00K 10-Q · filed 2025-11-12 | -$7.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$1.00K 10-Q · filed 2026-08-14 | -$7.00K 10-Q · filed 2026-08-14 | -$7.00K derived: sum of 3 quarters · filed 2026-08-14 | -$23.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$6.00K S-1/A · filed 2026-08-10 | -$6.00K derived: sum of 2 quarters · filed 2026-08-10 | -$22.00K derived: sum of 3 quarters · filed 2026-08-10 | -$22.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2024-12-31 | $0.00 derived: S-1/A 12 month − 10-Q 9 month · filed 2026-08-10 | -$16.00K derived: sum of 2 quarters · filed 2026-08-10 | -$16.00K derived: sum of 3 quarters · filed 2026-08-10 | -$22.00K S-1/A · filed 2026-08-10 |
| 2024-09-30 | -$16.00K 10-Q · filed 2025-11-12 | -$16.00K derived: sum of 2 quarters · filed 2025-11-12 | -$22.00K 10-Q · filed 2025-11-12 | -$26.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-12 | -$6.00K 10-Q · filed 2025-08-12 | -$10.00K derived: sum of 3 quarters · filed 2025-08-20 | $62.00K derived: sum of 4 quarters · filed 2025-08-20 |
| 2024-03-31 | -$6.00K 10-Q · filed 2025-05-13 | -$10.00K derived: sum of 2 quarters · filed 2025-08-20 | $62.00K derived: sum of 3 quarters · filed 2025-08-20 | $60.00K derived: sum of 4 quarters · filed 2025-08-20 |
| 2023-12-31 | -$4.00K derived: 8-K 12 month − 10-Q 9 month · filed 2025-08-20 | $68.00K derived: sum of 2 quarters · filed 2025-08-20 | $66.00K derived: sum of 3 quarters · filed 2025-08-20 | $573.00K 8-K · filed 2025-08-20 |
| 2023-09-30 | $72.00K 10-Q · filed 2024-11-14 | $70.00K derived: sum of 2 quarters · filed 2024-11-14 | $577.00K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | -$2.00K 10-Q · filed 2024-08-29 | $505.00K 10-Q · filed 2024-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |